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It has been reported that 50 to 60 percent of seronegative
patients developed serologic or V i r o l o g i e evidence of CMV
infec t ion f o l l o w i n g extra corporeal pe r fus ion ( E m b i l 1968).
Twenty-five percent of exchange transfused neonates were
shown to acqu i r e CMV infect ion weeks after the procedure
(Benson 1979). Yeager reported in 1981 that 13.5 percent
of newborns became seropositive for CMV after blood
t rans fus ion . There is evidence that CMV may be transmitted
by leukocytes w h i c h harbor the v i r u s in the infected donors
b I ood.
Since it is pos s ib l e to remove p o t e n t i a l l y infec t ious
leukocytes from the donnor 's blood by the technique of
f reez ing and w a s h i n g , the purpose of this study is to f i n d
out if t rans fus ions of frozen reconstituted RBC w o u l d prevent
or reduce the inc idence of t ransfus ion acqui red CMV in fec t ion .
Mate r i a l and method: Th i s prospective study randomly selects
neonates r e q u i r i n g elective blood t r ans fus ion . F i f t y study
in fan t s are to receive frozen reconstituted RBC w h i l e 50
control i n f an t s are to receive o rd ina ry packed RBC. Frozen
reconstituted RBC is prepared by f o l l o w i n g steps: 1. Removal
of p l a s m a . 2. A d d i t i o n of 28% g lyce ro l . 3. Freezing in
l i q u i d ni t rogen. 4. T h a w i n g in 45 C water bath. 5. Removal
of glycerol by mani to I so lu t ion . 6. Wash in normal s a l i n e
3 t imes. 7. Resuspend in s a l i n e . 8. A d d i t i o n of glucose.
M a t e r n a l , cord and donnor 's blood are tested for CMV
complement f i xa t i on titers u s i n g more potent g l y c i n e extracted
ant igen . The f o l l o w - u p serologic studies of the in fan t s
are carr ied out at 8 and 16 weeks after the i n i t i a l
t r ans fus ion . U r i n e is cu l tu red for CMV at b i r t h and at
the same f o l l o w - u p schedule . T rans fus ion acqui red CMV
infec t ion is d e f i n e d as seroconversion, persistent r i s i n g
CMV titer and/or evidence of posit ive u r i n e cu l tu re after
transfusions.
Resul t : So far 71 mother i n f a n t pa i r s have been s tudied
up to 8 to 16 weeks after i n i t i a l t ransfus ions . F i f t y - s i x
percent of mothers and 54% of donnors were seropositive
(CMV titer > 1 : 8 ) . Eighty-seven percent of i n f an t s born
to seropositive mothers were a lso scropositive. Twenty-nine
in fan t s received frozen reconstituted blood t ransfusions
and 7 were transfused w i t h r egu la r blood w i t h negative CMV
titers. None of these 36 in fan t s had evidence of CMV
infec t ion at 8 and 16 weeks f o l l o w - u p . W h i l e n i n e of 35
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infants who have received regula r blood wi th positive CMV
titer showed seroconversion or r i s i n g titers1 at 8 and 16
weeks after t r ans fus ion . (Tab le I ) This d i f ference i s
s ta t i s t ica l ly s i g n i f i c a n t at the p v a l u e of less than 0.01
(X2=6.68).
Comparison of 9 infected and 26 non-infected in fan t s who
received regular RBC w i t h CMV posit ive titers revealed no
di f fe rence in the number of positive donors, volume of blood
w i t h posit ive titers, and total volume transfused. There
was, however, a s i g n i f i c a n t d i f f e r ence (p <0.02) in the
donor's CMV titers of the two groups (Tab le II) Those who
were not infected were transfused w i t h blood of h ighe r CMV
titers than those who acqu i red infec t ion . Th is may i m p l y
that the h igher donor's titer may be protective to the
recipient . Th i s study is but h a l f way completed. So far
there is some evidence to show that: 1. t ransfusion w i t h
frozen reconsituted RBC may prevent t ransfus ion acqui red
CMV in fec t ion , 2. the presence of a CMV posit ive titer does
not necessari ly i m p l y potential i n f ec t iv i t y , 3. the h ighe r
CMV titer of donor's blood may be protective of CMV infec t ion .
Table I . TRANSFUSION ACQUIRED CMV I N F E C T I O N
Donor 's Blood
Frozen RBC
R e g u l a r RBC
R e g u l a r RBC
Donor's
CMV Titer
0
Post Trans fus ion
No. Pts. CMV Infect ion ( % )
29 0 (0)
7 0 (0)
35 9 (23)p<0.01
Tab le I I . COMPARISON OF INFECTED VS NON- INFECTED INFANTS
No.
Number
Transfus ions
No CMV(+)
Donor's
V o l u m e ( m l )
CMV(+) Blood
Tot Vol ( m l )
Transfused
No CMV
Titer > 1 : 3 2 ( % )
*Student T test
**X2 Test
CMV
Infected
9
5.4±3.6
2.U1.5
33±18
103±54
2/8 (257.)
Non-CMV
i nfected
26
9.0±6.0
2.3±1.3
34±19
144±119
17/22(77f.)
<0.05
NS
NS
NS
<0.02**
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